125 related articles for article (PubMed ID: 1663734)
1. Antiviral activity of the prostanoid clavulone II against vesicular stomatitis virus.
Bader T; Yamada Y; Ankel H
Antiviral Res; 1991 Dec; 16(4):341-55. PubMed ID: 1663734
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of primary transcription of vesicular stomatitis virus by prostaglandin A1.
Bader T; Ankel H
J Gen Virol; 1990 Dec; 71 ( Pt 12)():2823-32. PubMed ID: 2177081
[TBL] [Abstract][Full Text] [Related]
3. Antiviral effect of cyclopentenone prostaglandins on vesicular stomatitis virus replication.
Parker J; Ahrens PB; Ankel H
Antiviral Res; 1995 Jan; 26(1):83-96. PubMed ID: 7537950
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin A inhibits the replication of vesicular stomatitis virus: effect on virus glycoprotein.
Santoro MG; Jaffe BM; Esteban M
J Gen Virol; 1983 Dec; 64 ( Pt 12)():2797-801. PubMed ID: 6198441
[TBL] [Abstract][Full Text] [Related]
5. Effect of combined alpha IFN and prostaglandin A1 treatment on vesicular stomatitis virus replication and heat shock protein synthesis in epithelial cells.
Pica F; Rossi A; Santirocco N; Palamara A; Garaci E; Santoro MG
Antiviral Res; 1996 Mar; 29(2-3):187-98. PubMed ID: 8739598
[TBL] [Abstract][Full Text] [Related]
6. Vesicular stomatitis viruses resistant to the methylase inhibitor sinefungin upregulate RNA synthesis and reveal mutations that affect mRNA cap methylation.
Li J; Chorba JS; Whelan SP
J Virol; 2007 Apr; 81(8):4104-15. PubMed ID: 17301155
[TBL] [Abstract][Full Text] [Related]
7. Vesicular Stomatitis Virus Transcription Is Inhibited by TRIM69 in the Interferon-Induced Antiviral State.
Kueck T; Bloyet LM; Cassella E; Zang T; Schmidt F; Brusic V; Tekes G; Pornillos O; Whelan SPJ; Bieniasz PD
J Virol; 2019 Dec; 93(24):. PubMed ID: 31578292
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of vesicular stomatitis virus replication by prostaglandin A1 in Aedes albopictus cells.
Burlandy FM; Ferreira DF; Rebello MA
Z Naturforsch C J Biosci; 2004; 59(1-2):127-31. PubMed ID: 15018065
[TBL] [Abstract][Full Text] [Related]
9. Studies on the antiviral activity of protein kinase inhibitors against the replication of vesicular stomatitis virus.
Kim YS; Sagara J; Kawai A
Biol Pharm Bull; 1995 Jun; 18(6):895-9. PubMed ID: 7550128
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of anti-vesicular stomatitis virus activity of deazaneplanocin and its 3-brominated analogs.
Gibbons JS; Khadka S; Williams CG; Wang L; Schneller SW; Liu C; Tufariello JM; Basler CF
Antiviral Res; 2021 Jul; 191():105088. PubMed ID: 34019950
[TBL] [Abstract][Full Text] [Related]
11. Studies on the antiviral mechanisms of protein kinase inhibitors K-252a and KT5926 against the replication of vesicular stomatitis virus.
Kim YS; Kawai A
Biol Pharm Bull; 1998 May; 21(5):498-505. PubMed ID: 9635507
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of vesicular stomatitis virus replication by delta 12-prostaglandin J2 is regulated at two separate levels and is associated with induction of stress protein synthesis.
Pica F; De Marco A; De Cesare F; Santoro MG
Antiviral Res; 1993 Mar; 20(3):193-208. PubMed ID: 8385894
[TBL] [Abstract][Full Text] [Related]
13. Antiviral effect of a synthetic brassinosteroid on the replication of vesicular stomatitis virus in Vero cells.
Romanutti C; Castilla V; Coto CE; Wachsman MB
Int J Antimicrob Agents; 2007 Mar; 29(3):311-6. PubMed ID: 17275263
[TBL] [Abstract][Full Text] [Related]
14. The effect of cicloxolone sodium on the replication of vesicular stomatitis virus in BSC-1 cells.
Dargan DJ; Galt CB; Subak-Sharpe JH
J Gen Virol; 1992 Feb; 73 ( Pt 2)():397-406. PubMed ID: 1311361
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the phosphorylation of the regulatory non-structural protein of vesicular stomatitis virus by an antiviral xanthate compound.
Müller-Decker K; Amtmann E; Sauer G
J Gen Virol; 1987 Dec; 68 ( Pt 12)():3045-56. PubMed ID: 2447222
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of a vesicular stomatitis virus mutant by rifampin.
Moreau MC
J Virol; 1974 Sep; 14(3):517-21. PubMed ID: 4368821
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of vesicular stomatitis virus protein synthesis and infection by sequence-specific oligodeoxyribonucleoside methylphosphonates.
Agris CH; Blake KR; Miller PS; Reddy MP; Ts'o PO
Biochemistry; 1986 Oct; 25(20):6268-75. PubMed ID: 3024704
[TBL] [Abstract][Full Text] [Related]
18. Antiviral activity and possible mechanisms of action of oligonucleotides-poly(L-lysine) conjugates targeted to vesicular stomatitis virus mRNA and genomic RNA.
Degols G; Leonetti JP; Gagnor C; Lemaitre M; Lebleu B
Nucleic Acids Res; 1989 Nov; 17(22):9341-50. PubMed ID: 2479915
[TBL] [Abstract][Full Text] [Related]
19. Antiviral activity of prostaglandin A on encephalomyocarditis virus-infected cells: a unique effect unrelated to interferon.
Ankel H; Mittnacht S; Jacobsen H
J Gen Virol; 1985 Nov; 66 ( Pt 11)():2355-64. PubMed ID: 2414395
[TBL] [Abstract][Full Text] [Related]
20. In vitro inhibition of vesicular stomatitis virus replication by purified porcine Mx1 protein fused to HIV-1 Tat protein transduction domain (PTD).
Zhang XM; He DN; Zhou B; Pang R; Liu K; Zhao J; Chen PY
Antiviral Res; 2013 Aug; 99(2):149-57. PubMed ID: 23727591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
